| Code | Display |
| HX01 |
Genomic testing (Haemato-Oncology) Not in National Genomic Test Directory |
| MX01.1 |
Genomic testing (Solid Tumour), Not in National Genomic Test Directory |
| MX02.1 |
BRAF V600E Testing, Lynch syndrome |
| MX04.1 |
DNA to be stored, Cancer (Other) |
| MX05.1 |
RNA to be stored, Cancer (Other) |
| MX07.1 |
FaR-RMS trial, Multi-target NGS Panel, small variant |
| MX07.2 |
FaR-RMS trial, Multi-target NGS panel, structural variant |
| MX08.1 |
Melanoma, Detection trial, small variant (BRAF, NRAS, TERT) |
| MX10.1 |
Triple-Negative Myeloproliferative Neoplasm (MPN), MPL non-canonical variant screening |
| MX11.1 |
Acute Myeloid Leukaemia (AML), FLT3-ITD MRD |
| MX12.1 |
Large-Cell Neuroendocrine Carcinoma (LCNEC) Project |
| MX13.1 |
Colorectal Cancer, Multi-target ctDNA NGS panel, small variant |
| MX14.1 |
Cancer of Unknown Primary, Multi-target ctDNA NGS panel, small variant |
| RX01.1 |
Genomic testing (Rare Disease) Not in National Genomic Test Directory |
| RX02.1 |
Genomic testing Research Study |
| RX03.1 |
Complement Tx i-Gain Clinical Trial |
| RX03.2 |
Genomic testing Clinical Trial |
| RX04.1 |
Molecular Pathology of Human Genetic Disease (HumGenDis) |
| RX05.1 |
LEAP Study |
| RX06.1 |
Implementing Pharmocogenetics to Improve Prescribing (IPTIP) |
| RX07.1 |
TPMT (Thiopurine S-methyltransferase) genotyping (Targeted variant testing) |
| RX08.1 |
Factor V Leiden and Prothrombin thrombophilia (FVL and PGV) |
| RX09.1 |
Genome-wide DNA Methylation Profiling (Methylation testing) |
| RX11.1 |
Jewish BRCA Project Germline Screening |
| RX16.1 |
FOVEA Study |
| RX18.1 |
Inherited ovarian cancer (without breast cancer) RetroBRCA Project |
| RX18.2 |
Inherited breast cancer and ovarian cancer RetroBRCA Project |
| RX19.1 |
PROGRESS Study |
| RX20.1 |
Renal Tract Abnormalities Study |
| RX21.1 |
Ashkenazi Jewish and Polish Population Screening (Targeted variant testing) |
| XX01.1 |
Not Processed (No Extraction) |
| XX02.1 |
Cell line extraction & aliquot for DNA storage (Other) |